Frontier mental health research: psychedelics & drug studies

Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.

8 papers

The serotonin theory of depression: a systematic umbrella review of the evidence

Moncrieff, Joanna, Cooper, Ruth E., Stockmann, Tom, et al.
Nature Summary & key facts 2023 830 citations

This umbrella review looked at the best existing reviews and large studies to see if depression is linked to low serotonin or low serotonin activity. Across measures of serotonin in fluids, receptor and transporter studies, tryptophan depletion experiments, and large genetic studies, the evidence was mixed or absent. The authors…

Mental Health Research Topics Treatment of Major Depression Tryptophan and brain disorders

Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway

Nora D. Volkow, Gou‐Jen Wang, Jeffrey H. Newcorn, Scott H. Kollins, Timothy Wigal, Frank Telang, et al.
Molecular Psychiatry Summary & key facts 2010 409 citations

Researchers used PET brain scans to compare dopamine reward-system markers in 45 adults with ADHD and 41 adults without ADHD. People with ADHD scored lower on an Achievement scale (a stand-in measure for motivation), and in the ADHD group those lower scores were linked to lower availability of dopamine D2/D3…

Attention Deficit Hyperactivity Disorder Cognitive Abilities and Testing Neural and Behavioral Psychology Studies

Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors

Vesna Lazarevic, Yunting Yang, Ivana Flais, Per Svenningsson
Molecular Psychiatry Summary & key facts 2021 71 citations

This study in rodents and in neuronal cell cultures found that ketamine and its antidepressant metabolite (2R,6R)-HNK rapidly lower neuronally released glutamate in brain regions linked to depression. Using fast glutamate sensors (FAST), isolated synapses, and primary cortical neurons, the authors showed reduced depolarization-evoked glutamate release within 30 minutes after…

Neuroscience and Neuropharmacology Research Treatment of Major Depression Tryptophan and brain disorders

Imaging the effect of ketamine on synaptic density (SV2A) in the living brain

Sophie Holmes, Sjoerd J. Finnema, Mika Naganawa, Nicole DellaGioia, Daniel Holden, Krista Fowles, et al.
Molecular Psychiatry Summary & key facts 2022 67 citations

The researchers used PET scans with [11C]UCB-J to measure SV2A, a protein that marks presynaptic nerve terminals, and tested whether a single ketamine dose changes synaptic density in the living brain. Overall, they did not find a measurable change in SV2A 24 hours after one ketamine dose in non-human primates,…

Functional Brain Connectivity Studies Neuroscience and Neuropharmacology Research Treatment of Major Depression

Mania-related effects on structural brain changes in bipolar disorder – a narrative review of the evidence

Christoph Abé, Benny Liberg, Anna Luisa Klahn, Predrag Petrovic, Mikael Landén
PubMed Central (PMC) Summary & key facts 2023 39 citations

Long-term MRI studies show that people with bipolar disorder often have unusual brain changes over time, but the pattern is mixed and not fully clear. Some studies link manic episodes to faster thinning and volume loss in parts of the prefrontal cortex. A large multi-site study (307 patients, 925 controls,…

Bipolar Disorder and Treatment Functional Brain Connectivity Studies Schizophrenia research and treatment

Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis

Abigail E. Calder, Adrian Hase, Gregor Hasler
Molecular Psychiatry Summary & key facts 2024 10 citations

Researchers pooled results from 29 human studies that measured blood levels of a protein called brain-derived neurotrophic factor, or BDNF, after people received so-called psychoplastogen drugs such as ketamine or psychedelics. They found no clear change in blood BDNF after these drugs. The authors say this does not prove the…

Neurotransmitter Receptor Influence on Behavior Psychedelics and Drug Studies Treatment of Major Depression Ayahuasca Ketamine

Risk of suicide and all-cause death in patients with mental disorders: a nationwide cohort study

Hyewon Kim, Jin‐Hyung Jung, Kyungdo Han, Hong Jin Jeon
Molecular Psychiatry Summary & key facts 2025 9 citations

This large South Korean study followed 3,951,398 adults for an average of 11.1 years to compare deaths in people with and without recorded mental disorders. After adjusting for age, sex, health conditions, income, smoking, drinking and physical activity, people with mental disorders had higher rates of suicide and higher overall…

Bipolar Disorder and Treatment Mental Health Treatment and Access Suicide and Self-Harm Studies

Prevalence of attention deficit hyperactivity disorder/hyperkinetic disorder of pediatric and adult populations in clinical settings: a systematic review, meta-analysis and meta-regression

S.C. Johnson, Eric Lim, Peter Jacoby, Stephen V. Faraone, Benjamin Minche Su, Marco Solmi, et al.
Molecular Psychiatry Summary & key facts 2025 2 citations

This systematic review and meta-analysis combined 311 clinical studies (653,558 children and 43,311 adults) up to August 1, 2023. It found that ADHD/hyperkinetic disorder occurred in 32.4% (95% CI 31–34%) of pediatric patients and 21.4% (95% CI 20–23%) of adult patients seen in clinical settings — about 8–9 times higher…

Attention Deficit Hyperactivity Disorder Bipolar Disorder and Treatment
Summaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.